Question · asked by 1 review

Intranasal neostigmine vs placebo: Improved muscle function various methods1

It is very uncertain whether intranasal neostigmine changes improved muscle function various methods1 compared with placebo (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Intranasal neostigmine vs placebo
Improved muscle function various methods1 · people with myasthenia gravis
Acetylcholinesterase inhibitor treatment for myasthenia gravis (2014) · Cochrane Headline outcomes only
no estimate extracted10 participantsVery low
Intranasal neostigmine vs placebo
Improved muscle function various methods1 · people with myasthenia gravis
It is very uncertain whether intranasal neostigmine changes improved muscle function various methods1 compared with placebo (very low certainty).
Acetylcholinesterase inhibitor treatment for myasthenia gravis (2011) · Cochrane Headline outcomes onlyearlier version CD006986.PUB2, superseded
RR 19 [1.25, 287.92]1 study · 20 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Acetylcholinesterase inhibitor treatment for myasthenia gravis
2014 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.